5 февр. 2024 г. · Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.

4 нояб. 2024 г. · EU antitrust regulators will decide by Dec. 6 whether to clear Novo Holdings' acquisition of contract drug manufacturer Catalent (CTLT.N).

30 окт. 2024 г. · When Novo Nordisk's holding company announced plans to acquire contract manufacturer Catalent for $16.5 billion in February, the deal faced ...

11 окт. 2024 г. · Under the deal, Novo Nordisk plans to take three of Catalent's manufacturing sites to bolster production of its blockbuster diabetes drug ...

8 февр. 2024 г. · Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5bn on an enterprise value basis.

23 окт. 2024 г. · Under the current plan, Novo Nordisk is in line to purchase three Catalent fill-finish facilities from Novo Holdings for $11 billion after the ...

21 окт. 2024 г. · Catalent's acquisition by Novo Holdings is expected to close towards the end of calendar year 2024, subject to customary closing conditions.

Catalent has entered into an agreement to be acquired by Novo Holdings, a global investment firm focused on life sciences.

10 окт. 2024 г. · While Novo Holdings hopes the Catalent acquisition could close before the end of 2024, the deal has faced several delays already. Following “ ...